Actively Recruiting
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
Led by Yale University · Updated on 2026-02-23
60
Participants Needed
1
Research Sites
82 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a double blind, placebo controlled, randomized trial of study subjects with PCOS and low vitamin D to 2 groups- placebo and vitamin D replacement. Participants and investigators will be blinded to treatment modality until the end of the trial period
CONDITIONS
Official Title
Evaluation of the Clinical and Psychological Impact of Vitamin D Replacement in Adolescent Females at Risk for Polycystic Ovarian Syndrome (PCOS)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Postmenarchal adolescent females aged 13 to 21
- Meet modified Rotterdam criteria for PCOS
- Serum vitamin D level between 6 and 29 ng/mL
You will not qualify if you...
- Other causes for hyperandrogenism
- Chronic kidney diseases
- Acquired or inherited calcium and vitamin D metabolic disorders
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Yale New Haven Children's Hospital
New Haven, Connecticut, United States, 06510
Actively Recruiting
Research Team
A
Alla Vash-Margita, MD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
DOUBLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here